| NDC Code: |
42291-889 |
| Proprietary Name: |
Valacyclovir Hydrochloride |
| Suffix: |
|
| Non-Proprietary Name: |
Valacyclovir Hydrochloride |
| Dosage Form: |
TABLET, FILM COATED |
| Method: |
ORAL |
| Original Marketing Date: |
11-07-2013 |
| Category Name: |
ANDA |
| Application Number: |
ANDA077655 |
| Labeler: |
AVKARE, INC. |
| Substance Name: |
VALACYCLOVIR HYDROCHLORIDE |
| Active Numerator Strength: |
1 |
| Active Ingredient Unit: |
g/1 |
| Pharm Classes: |
DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
| DEA Schedule: |
|
